Cargando…
Risk of carotid blowout after reirradiation with particle therapy
PURPOSE: Carotid blowout (CB) is a serious complication in retreatment of neoplasms in the head and neck (H&N) region. Rates seem to increase in hypofractionated or accelerated hyperfractionated regimens. In this study, we investigate the CB rate and the cumulative doses received by the carotid...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605322/ https://www.ncbi.nlm.nih.gov/pubmed/29114615 http://dx.doi.org/10.1016/j.adro.2017.05.007 |
_version_ | 1783264967273742336 |
---|---|
author | Dale, Jon Espen Molinelli, Silvia Ciurlia, Elisa Ciocca, Mario Bonora, Maria Vitolo, Viviana Mirandola, Alfredo Russo, Stefania Orecchia, Roberto Dahl, Olav Fossati, Piero |
author_facet | Dale, Jon Espen Molinelli, Silvia Ciurlia, Elisa Ciocca, Mario Bonora, Maria Vitolo, Viviana Mirandola, Alfredo Russo, Stefania Orecchia, Roberto Dahl, Olav Fossati, Piero |
author_sort | Dale, Jon Espen |
collection | PubMed |
description | PURPOSE: Carotid blowout (CB) is a serious complication in retreatment of neoplasms in the head and neck (H&N) region. Rates seem to increase in hypofractionated or accelerated hyperfractionated regimens. In this study, we investigate the CB rate and the cumulative doses received by the carotid artery (CA) in a cohort of patients who were reirradiated at CNAO with particle therapy in the H&N region. METHODS AND MATERIALS: The dosimetric information, medical records, and tumor characteristics of 96 patients were analyzed. For 49 of these patients, the quality of dosimetric information was sufficient to calculate the cumulative doses to the CA. The corresponding biological equivalent dose in 2 Gy fractions (EQD2) was calculated with an α/β-ratio of 3. RESULTS: In the final reirradiation at CNAO, 17 patients (18%) had been treated with protons and 79 (82%) with carbon ions. Two patients experienced profuse oronasal bleeding, of which one case was confirmed to be caused by CB. If attributing both cases to CB, we found an actuarial CB rate of 2.7%. Interestingly, there were no CB cases in the carbon ion group even though this was the large majority of patients and they generally were treated more aggressively in terms of larger fraction doses and higher cumulative EQD2. CONCLUSIONS: The current practice of particle reirradiation at CNAO for recurrent neoplasms in the H&N region results in acceptable rates of CB. |
format | Online Article Text |
id | pubmed-5605322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-56053222017-11-07 Risk of carotid blowout after reirradiation with particle therapy Dale, Jon Espen Molinelli, Silvia Ciurlia, Elisa Ciocca, Mario Bonora, Maria Vitolo, Viviana Mirandola, Alfredo Russo, Stefania Orecchia, Roberto Dahl, Olav Fossati, Piero Adv Radiat Oncol Scientific Article PURPOSE: Carotid blowout (CB) is a serious complication in retreatment of neoplasms in the head and neck (H&N) region. Rates seem to increase in hypofractionated or accelerated hyperfractionated regimens. In this study, we investigate the CB rate and the cumulative doses received by the carotid artery (CA) in a cohort of patients who were reirradiated at CNAO with particle therapy in the H&N region. METHODS AND MATERIALS: The dosimetric information, medical records, and tumor characteristics of 96 patients were analyzed. For 49 of these patients, the quality of dosimetric information was sufficient to calculate the cumulative doses to the CA. The corresponding biological equivalent dose in 2 Gy fractions (EQD2) was calculated with an α/β-ratio of 3. RESULTS: In the final reirradiation at CNAO, 17 patients (18%) had been treated with protons and 79 (82%) with carbon ions. Two patients experienced profuse oronasal bleeding, of which one case was confirmed to be caused by CB. If attributing both cases to CB, we found an actuarial CB rate of 2.7%. Interestingly, there were no CB cases in the carbon ion group even though this was the large majority of patients and they generally were treated more aggressively in terms of larger fraction doses and higher cumulative EQD2. CONCLUSIONS: The current practice of particle reirradiation at CNAO for recurrent neoplasms in the H&N region results in acceptable rates of CB. Elsevier 2017-07-06 /pmc/articles/PMC5605322/ /pubmed/29114615 http://dx.doi.org/10.1016/j.adro.2017.05.007 Text en © 2017 The Authors on behalf of the American Society for Radiation Oncology http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Scientific Article Dale, Jon Espen Molinelli, Silvia Ciurlia, Elisa Ciocca, Mario Bonora, Maria Vitolo, Viviana Mirandola, Alfredo Russo, Stefania Orecchia, Roberto Dahl, Olav Fossati, Piero Risk of carotid blowout after reirradiation with particle therapy |
title | Risk of carotid blowout after reirradiation with particle therapy |
title_full | Risk of carotid blowout after reirradiation with particle therapy |
title_fullStr | Risk of carotid blowout after reirradiation with particle therapy |
title_full_unstemmed | Risk of carotid blowout after reirradiation with particle therapy |
title_short | Risk of carotid blowout after reirradiation with particle therapy |
title_sort | risk of carotid blowout after reirradiation with particle therapy |
topic | Scientific Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605322/ https://www.ncbi.nlm.nih.gov/pubmed/29114615 http://dx.doi.org/10.1016/j.adro.2017.05.007 |
work_keys_str_mv | AT dalejonespen riskofcarotidblowoutafterreirradiationwithparticletherapy AT molinellisilvia riskofcarotidblowoutafterreirradiationwithparticletherapy AT ciurliaelisa riskofcarotidblowoutafterreirradiationwithparticletherapy AT cioccamario riskofcarotidblowoutafterreirradiationwithparticletherapy AT bonoramaria riskofcarotidblowoutafterreirradiationwithparticletherapy AT vitoloviviana riskofcarotidblowoutafterreirradiationwithparticletherapy AT mirandolaalfredo riskofcarotidblowoutafterreirradiationwithparticletherapy AT russostefania riskofcarotidblowoutafterreirradiationwithparticletherapy AT orecchiaroberto riskofcarotidblowoutafterreirradiationwithparticletherapy AT dahlolav riskofcarotidblowoutafterreirradiationwithparticletherapy AT fossatipiero riskofcarotidblowoutafterreirradiationwithparticletherapy |